M. Ruel, T. A. Khan, P. Voisine, C. Bianchi, and F. W. Sellke, Vasomotor dysfunction after cardiac surgery, European Journal of Cardio-Thoracic Surgery, vol.26, pp.1002-1016, 2004.

A. Mekontso-dessap, R. Houël, C. Soustelle, M. Kirsch, D. Thébert et al., Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function, Ats, vol.71, pp.1428-1460, 2001.

M. A. Levin, H. Lin, J. G. Castillo, D. H. Adams, D. L. Reich et al., Early oncardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome, Circulation, vol.120, pp.1664-71, 2009.

G. W. Fischer and M. A. Levin, Vasoplegia during cardiac surgery: current concepts and management, Seminars in Thoracic and Cardiovascular Surgery, vol.22, pp.140-144, 2010.

J. Feng, L. M. Chu, M. P. Robich, R. T. Clements, K. R. Khabbaz et al., Effects of cardiopulmonary bypass on endothelin-1-induced contraction and signaling in human skeletal muscle microcirculation, Circulation, vol.122, pp.150-155, 2010.

T. A. Khan, C. Bianchi, M. Ruel, P. Voisine, J. Li et al., Mitogen-activated protein kinase inhibition and cardioplegia-cardiopulmonary bypass reduce coronary myogenic tone, Circulation, vol.108, issue.1, pp.348-53, 2003.

S. M. Zhang, L. Zuo, Q. Zhou, S. Y. Gui, R. Shi et al., Expression and distribution of endocan in human tissues, Biotech Histochem, vol.87, pp.172-180, 2012.

P. Lassalle, S. Molet, A. Janin, J. V. Heyden, J. Tavernier et al., ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines, J Biol Chem, vol.271, pp.20458-64, 1996.

D. Bechard, V. Meignin, A. Scherpereel, S. Oudin, G. Kervoaze et al., Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies, J Vasc Res, vol.37, pp.417-442, 2000.

D. Bechard, A. Scherpereel, H. Hammad, T. Gentina, A. Tsicopoulos et al., Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/ CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1, J Immunol, vol.167, pp.3099-106, 2001.

A. Scherpereel, F. Depontieu, B. Grigoriu, B. Cavestri, A. Tsicopoulos et al.,

, Endocan, a new endothelial marker in human sepsis, Crit Care Med, vol.34, pp.532-539, 2006.

M. E. Mikkelsen, C. V. Shah, A. Scherpereel, P. N. Lanken, P. Lassalle et al., Lower serum endocan levels are associated with the development of acute lung injury after major trauma, Journal of Critical Care, vol.27, pp.522-533, 2012.

S. Stoppelkamp, K. Veseli, K. Stang, C. Schlensak, H. P. Wendel et al., Identification of Predictive Early Biomarkers for Sterile-SIRS after Cardiovascular Surgery, PLoS One, vol.10, p.135527, 2015.

P. R. Madhivathanan, N. Fletcher, D. Gaze, R. Thomson, V. Chandrasekaran et al., Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass, Cytokine, vol.83, pp.8-12, 2016.

A. Perrotti, C. Chenevier-gobeaux, F. Ecarnot, K. Bardonnet, B. Barrucand et al., Is Endocan a Diagnostic Marker for Pneumonia After Cardiac Surgery? The ENDOLUNG Study, Ann Thorac Surg, 2017.

J. Amour, M. Garnier, J. Szymezak, L. Manach, Y. Helley et al., Prospective observational study of the effect of dual antiplatelet therapy with tranexamic acid treatment on platelet function and bleeding after cardiac surgery, Br J Anaesth, vol.117, pp.749-57, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01472329

V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel, and C. K. Haan, Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline, Society of Thoracic Surgeons Blood Conservation Guideline Task Force, vol.83, pp.27-86, 2007.

J. M. Bland and D. G. Altman, Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects, Bmj, vol.310, p.446, 1995.

J. M. Bland and D. G. Altman, Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects, Bmj, vol.310, p.633, 1995.

T. Çimen, T. H. Efe, A. Akyel, H. Sunman, E. Algül et al., Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina, Angiology, vol.67, pp.846-53, 2016.

X. Wang, Y. W. Luo, T. Wang, J. Jing, and Y. , Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension, Genet Test Mol Biomarkers, vol.19, pp.124-131, 2015.

T. Cel?k, S. Balta, M. Karaman, A. Ay, S. Dem?rkol et al., Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan, Blood Press, vol.24, pp.55-60, 2015.

A. Aouifi, V. Piriou, P. Blanc, H. Bouvier, O. Bastien et al., Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations, Br J Anaesth, vol.83, pp.602-609, 1999.

F. Stéphan, B. Barrucand, P. Petit, S. Rézaiguia-delclaux, A. Médard et al., High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery: A Randomized Clinical Trial, Jama, vol.313, pp.2331-2340, 2015.